{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "HDL",
      "Immune system",
      "Metabolomics",
      "SARS-CoV-2",
      "lipids"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34313294",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "24"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "08",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "BSR20210953",
      "10.1042/BSR20210953"
    ],
    "Journal": {
      "ISSN": "1573-4935",
      "JournalIssue": {
        "Volume": "41",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug",
          "Day": "27"
        }
      },
      "Title": "Bioscience reports",
      "ISOAbbreviation": "Biosci Rep"
    },
    "ArticleTitle": "A lipidomic view of SARS-CoV-2.",
    "Abstract": {
      "AbstractText": [
        "The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which started in late 2019, has caused huge social and economic losses. A growing number of investigators are focusing on understanding the interaction of SARS-CoV-2 with host cellular processes to find therapeutic approaches. New data suggest that lipid metabolism may play a significant role in regulating the response of immune cells like macrophages to viral infection, thereby affecting the outcome of the disease. Therefore, understanding the role of lipid metabolism could help develop new therapeutic approaches to mitigate the social and economic cost of coronavirus disease 2019 (COVID-19)."
      ],
      "CopyrightInformation": "\u00a9 2021 The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0001-6628-944X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, U.K."
          }
        ],
        "LastName": "Ebrahimi",
        "ForeName": "Kourosh H",
        "Initials": "KH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Oxford, U.K."
          }
        ],
        "LastName": "McCullagh",
        "ForeName": "James S O",
        "Initials": "JSO"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Biosci Rep",
    "NlmUniqueID": "8102797",
    "ISSNLinking": "0144-8463"
  },
  "CommentsCorrectionsList": [
    {
      "RefSource": "10.1042/BSR20204305"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "metabolism"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Homeostasis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "immunology"
      ],
      "DescriptorName": "Lipid Metabolism"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Lipidomics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "chemistry"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "The authors declare that there are no competing interests associated with the manuscript."
}